← Leaderboards
Masayuki Nakamori
State University Of New York At Albany
$714,320
Attributed
$2,142,960
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $590.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,142,960 · 1
By mechanism
R01$2,142,960 · 1
Top collaborators
- John A Berglund9 shared
- Kaalak Reddy9 shared
Most similar at State University Of New York At Albany
Same institution · by research overlap
- Kaalak Reddy$925,778
- Arun Richard Chandrasekaran$1,782,963
- Hannah Shorrock$1,148,018
Others in their field
Other Rising Stars on “Small Molecule Therapeutics”
- Kevin V Grimes · Stanford University$14,783,804
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Suma Babu · Massachusetts General Hospital$9,298,517
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- Kenneth Schultz · Trethera Corporation$8,791,449
Research focus
Small Molecule TherapeuticsDesignMuscular DystrophiesMyotonic DystrophyFamilyPolycyclic CompoundsSmall MoleculeTranscriptomicsRna-Binding ProteinsCell LineRna SplicingBiologyMolecularProteinsComplexGenetic TranscriptionIn VitroIn VivoSeriesCalorimetryBrainAnimal ModelCell SurvivalBiological Availability
Grant awards (9)
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$425,205
R01 · FY2025 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$69,192
R01 · FY2025 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$465,688
R01 · FY2024 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$69,192
R01 · FY2024 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$13,694
R01 · FY2024 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$488,445
R01 · FY2023 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$55,928
R01 · FY2023 · NS
Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy$45,776
R01 · FY2023 · NS
Design, synthesis and efficacy of new small molecule therapeutics to impede myotonic dystrophy$509,840
R01 · FY2022 · NS